Cargando…

210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza

BACKGROUND: Due to poor sensitivity, the FDA mandated that rapid influenza antigen (IAT) must be phased out by 2018. At our institution an on-site rapid influenza PCR (PCR) was implemented in emergency departments (ED) at the start of the 2016–2017 influenza season. The purpose of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Jonathan, Mercuro, Nicholas, Vahia, Amit, Rizvi, Hira, Hameed, Mujtaba, Abreu-Lanfranco, Odaliz, Bhargava, Pallavi, Samuel, Linoj, Alangaden, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253968/
http://dx.doi.org/10.1093/ofid/ofy210.223
_version_ 1783373616552869888
author Williams, Jonathan
Mercuro, Nicholas
Vahia, Amit
Rizvi, Hira
Hameed, Mujtaba
Abreu-Lanfranco, Odaliz
Bhargava, Pallavi
Samuel, Linoj
Alangaden, George
author_facet Williams, Jonathan
Mercuro, Nicholas
Vahia, Amit
Rizvi, Hira
Hameed, Mujtaba
Abreu-Lanfranco, Odaliz
Bhargava, Pallavi
Samuel, Linoj
Alangaden, George
author_sort Williams, Jonathan
collection PubMed
description BACKGROUND: Due to poor sensitivity, the FDA mandated that rapid influenza antigen (IAT) must be phased out by 2018. At our institution an on-site rapid influenza PCR (PCR) was implemented in emergency departments (ED) at the start of the 2016–2017 influenza season. The purpose of this study was to examine the impact of influenza PCR testing on antimicrobial utilization in the ED. METHODS: This multicenter quasiexperimental study included adults over the age of 50 who were tested for influenza, and discharged from the ED. Subjects were matched 2:1 by age, sex, month of testing, and ED site. The pre-implementation group had IAT (January–April 2016) and the post-implementation had PCR testing (January–April 2017). The primary outcome was antiviral utilization. Other outcomes included diagnostic yield, test turnaround time (TAT), receipt of antibiotics, and 30-day revisit. RESULTS: The PCR group of 116 patients (patients) were matched to 232 patients in IAT group (Table 1). Positive results for influenza were reported in 37.9% of PCR vs. 18.1% of IAT groups (P < 0.001); TAT 0.95 (0.75–1.4) hours in PCR vs. 0.60 (0.40–0.85) hours in IAT group (P < 0.001). Oseltamivir was initiated in the ED in 21% of PCR vs. 11% of IAT group (P < 0.001). An additional 28% in PCR group received oseltamivir at ED discharge vs. 15% in IAT group (P = 0.004). Antibiotics were administered in the ED to 8% in PCR group vs. 15% in the IAT group. A positive influenza test was associated with less antibiotic use OR 0.454 (95% CI 0.213–0.967), while abnormal chest radiograph (CXR) and WBC was associated with increased antibiotic use OR 3.667 (95% CI 1.743–7.715). The 30-day revisit was 3.8% and 10.8% in the PCR vs. IAT groups, respectively (P = 0.034). CONCLUSION: Replacing IAT with PCR testing increased diagnostic yield for influenza and receipt of oseltamivir and decreased antibiotic utilization in the ED. Independent predictors for antibiotic use were abnormal CXR and WBC, while positive influenza testing was protective. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253968
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62539682018-11-28 210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza Williams, Jonathan Mercuro, Nicholas Vahia, Amit Rizvi, Hira Hameed, Mujtaba Abreu-Lanfranco, Odaliz Bhargava, Pallavi Samuel, Linoj Alangaden, George Open Forum Infect Dis Abstracts BACKGROUND: Due to poor sensitivity, the FDA mandated that rapid influenza antigen (IAT) must be phased out by 2018. At our institution an on-site rapid influenza PCR (PCR) was implemented in emergency departments (ED) at the start of the 2016–2017 influenza season. The purpose of this study was to examine the impact of influenza PCR testing on antimicrobial utilization in the ED. METHODS: This multicenter quasiexperimental study included adults over the age of 50 who were tested for influenza, and discharged from the ED. Subjects were matched 2:1 by age, sex, month of testing, and ED site. The pre-implementation group had IAT (January–April 2016) and the post-implementation had PCR testing (January–April 2017). The primary outcome was antiviral utilization. Other outcomes included diagnostic yield, test turnaround time (TAT), receipt of antibiotics, and 30-day revisit. RESULTS: The PCR group of 116 patients (patients) were matched to 232 patients in IAT group (Table 1). Positive results for influenza were reported in 37.9% of PCR vs. 18.1% of IAT groups (P < 0.001); TAT 0.95 (0.75–1.4) hours in PCR vs. 0.60 (0.40–0.85) hours in IAT group (P < 0.001). Oseltamivir was initiated in the ED in 21% of PCR vs. 11% of IAT group (P < 0.001). An additional 28% in PCR group received oseltamivir at ED discharge vs. 15% in IAT group (P = 0.004). Antibiotics were administered in the ED to 8% in PCR group vs. 15% in the IAT group. A positive influenza test was associated with less antibiotic use OR 0.454 (95% CI 0.213–0.967), while abnormal chest radiograph (CXR) and WBC was associated with increased antibiotic use OR 3.667 (95% CI 1.743–7.715). The 30-day revisit was 3.8% and 10.8% in the PCR vs. IAT groups, respectively (P = 0.034). CONCLUSION: Replacing IAT with PCR testing increased diagnostic yield for influenza and receipt of oseltamivir and decreased antibiotic utilization in the ED. Independent predictors for antibiotic use were abnormal CXR and WBC, while positive influenza testing was protective. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253968/ http://dx.doi.org/10.1093/ofid/ofy210.223 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Williams, Jonathan
Mercuro, Nicholas
Vahia, Amit
Rizvi, Hira
Hameed, Mujtaba
Abreu-Lanfranco, Odaliz
Bhargava, Pallavi
Samuel, Linoj
Alangaden, George
210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
title 210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
title_full 210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
title_fullStr 210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
title_full_unstemmed 210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
title_short 210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
title_sort 210. improved antimicrobial utilization in the emergency department: impact of a point of care polymerase chain reaction test for the rapid detection influenza
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253968/
http://dx.doi.org/10.1093/ofid/ofy210.223
work_keys_str_mv AT williamsjonathan 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza
AT mercuronicholas 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza
AT vahiaamit 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza
AT rizvihira 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza
AT hameedmujtaba 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza
AT abreulanfrancoodaliz 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza
AT bhargavapallavi 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza
AT samuellinoj 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza
AT alangadengeorge 210improvedantimicrobialutilizationintheemergencydepartmentimpactofapointofcarepolymerasechainreactiontestfortherapiddetectioninfluenza